Earnings Report: 7 Stocks Expected to Report Earnings Soon
November 03, 2023 (Earnings Report)Dear Reader,We just identified several stocks that are expected to release earnings very soon.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
comScore
Symbol: SCOR
Recent Price: $0.63
Average Analyst Price Target: $12.25 (1846.92%)
Market Cap: $59.48M
Last Year's EPS: -0.13
Consensus EPS Forecast: -0.01869
Expected Earnings Date: 2023-08-08
Recent Analyst Action: Jason Kreyer, analyst at Craig-Hallum, reiterates coverage on comScore (SCOR) in the Technology sector with a Buy rating and a price target of $23 (1 week ago).
TipRanks.com also reports that comScore currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.25 . The target pricing ranges from a high forecast of $23 down to a low forecast of $1.5. comScore (SCOR)’s last closing price was $0.63 which would put the average price target at 1846.92% upside.Here are 3rd party ratings for SCOR:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Bottom 35% (162 out of 251)
--------------------------------------------------------------------------
eFFECTOR Therapeutics
Symbol: EFTR
Recent Price: $0.53
Average Analyst Price Target: $6.58 (1197.59%)
Market Cap: $33.20M
Last Year's EPS: -0.24
Consensus EPS Forecast: -0.19
Expected Earnings Date: 2023-08-08
Recent Analyst Action: Robert Burns, analyst at H.C. Wainwright, reiterates coverage on eFFECTOR Therapeutics (EFTR) in the Healthcare sector with a Buy rating and a price target of $5 (2 months ago).
TipRanks.com also reports that eFFECTOR Therapeutics currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $6.58 . The target pricing ranges from a high forecast of $7 down to a low forecast of $10. eFFECTOR Therapeutics (EFTR)’s last closing price was $0.53 which would put the average price target at 1197.59% upside.Here are 3rd party ratings for EFTR:
- TipRanks.com: Strong Buy
- TradingView.com:
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 31% (77 out of 251)
--------------------------------------------------------------------------
Durect
Symbol: DRRX
Recent Price: $2.69
Average Analyst Price Target: $29.80 (1007.81%)
Market Cap: $82.25M
Last Year's EPS: -0.52
Consensus EPS Forecast: -0.45
Expected Earnings Date: 2023-08-09
Recent Analyst Action: Carl Byrnes, analyst at Northland Securities, reiterates coverage on Durect (DRRX) in the Healthcare sector with a Buy rating and a price target of $12 (1 month ago).
TipRanks.com also reports that Durect currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $29.80 . The target pricing ranges from a high forecast of $41 down to a low forecast of $12. Durect (DRRX)’s last closing price was $2.69 which would put the average price target at 1007.81% upside.Here are 3rd party ratings for DRRX:
- TipRanks.com: Strong Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 37% (92 out of 251)
--------------------------------------------------------------------------
Sunshine Biopharma
Symbol: SBFM
Recent Price: $0.27
Average Analyst Price Target: $2.60 (862.96%)
Market Cap: $6.93M
Last Year's EPS: -0.08
Consensus EPS Forecast: n/a
Expected Earnings Date: 2023-08-11
Recent Analyst Action: David Bouchey, analyst at Aegis Capital, reiterates coverage on Sunshine Biopharma (SBFM) in the Healthcare sector with a Buy rating and a price target of $2.6 (2 months ago).
TipRanks.com also reports that Sunshine Biopharma currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $2.60 . The target pricing ranges from a high forecast of $2.6 down to a low forecast of $2.6. Sunshine Biopharma (SBFM)’s last closing price was $0.27 which would put the average price target at 862.96% upside.Here are 3rd party ratings for SBFM:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Forza X1, Inc.
Symbol: FRZA
Recent Price: $0.59
Average Analyst Price Target: $5.00 (750.77%)
Market Cap: $8.78M
Last Year's EPS: -0.19
Consensus EPS Forecast: n/a
Expected Earnings Date: 2023-08-07
Recent Analyst Action: Ashok Kumar, analyst at ThinkEquity, reiterates coverage on Forza X1, Inc. (FRZA) in the Technology sector with a Buy rating and a price target of $5 (1 month ago).
TipRanks.com also reports that Forza X1, Inc. currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.00 . The target pricing ranges from a high forecast of $5 down to a low forecast of $5. Forza X1, Inc. (FRZA)’s last closing price was $0.59 which would put the average price target at 750.77% upside.Here are 3rd party ratings for FRZA:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Eos Energy Enterprises
Symbol: EOSE
Recent Price: $1.85
Average Analyst Price Target: $11.75 (535.14%)
Market Cap: $227.79M
Last Year's EPS: -0.82
Consensus EPS Forecast: -0.35
Expected Earnings Date: 2023-08-14
Recent Analyst Action: James West, analyst at Evercore ISI, reiterates coverage on Eos Energy Enterprises (EOSE) in the Energy sector with a Buy rating and a price target of $17 (1 month ago).
TipRanks.com also reports that Eos Energy Enterprises currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $11.75 . The target pricing ranges from a high forecast of $5 down to a low forecast of $10. Eos Energy Enterprises (EOSE)’s last closing price was $1.85 which would put the average price target at 535.14% upside.Here are 3rd party ratings for EOSE:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Buy, Top 38% (95 out of 251)
--------------------------------------------------------------------------
Protalix
Symbol: PLX
Recent Price: $1.69
Average Analyst Price Target: $10.00 (491.72%)
Market Cap: $115.96M
Last Year's EPS: -0.05
Consensus EPS Forecast: 0.02897
Expected Earnings Date: 2023-08-07
Recent Analyst Action: Ram Selvaraju, analyst at H.C. Wainwright, reiterates coverage on Protalix (PLX) in the Healthcare sector with a Buy rating and a price target of $10 (3 days ago).
TipRanks.com also reports that Protalix currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00 . The target pricing ranges from a high forecast of $10 down to a low forecast of $10. Protalix (PLX)’s last closing price was $1.69 which would put the average price target at 491.72% upside.Here are 3rd party ratings for PLX:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, WallStreetSectors.com